Skip to main content

Table 4 Multivariate Cox regression analysis of sclerostin and new onset CV event (Age, gender-female, DM, HTN, CAD, BMI, sclerostin over 218.18 pmol/L, PH; pulmonary hypertension– pulmonary artery pressure > 35mmHg, backward method, Abbreviations: DM; diabetes mellitus, HTN; hypertension, CAD; coronary artery disease, BMI; body mass index)

From: Higher sclerostin is associated with pulmonary hypertension in pre-dialysis end-stage kidney disease patients: a cross-sectional prospective observational cohort study

Factors

Odds Ratio (95% CI)

P

Gender

2.09(0.68–6.46)

0.20

Age

1.01 (0.98–1.06)

0.43

DM

1.27(0.22–7.34)

0.79

HTN

1.76(0.12–25.70)

0.68

CAD

1.89(0.43–8.38)

0.40

BMI

0.86(0.71–1.05)

0.15

PH (> 35mmHg)

2.35(0.37–14.92)

0.36

Sclerostin

2.69(0.89–8.13)

0.08